Trial intelligence / Profile preview

Parecoxib 40 mg IV for Post-Operative Pain after Hemicolectomy

NCT00139607Phase 3Terminated

Sponsor
Pfizer
Start
Sep 2002
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of parecoxib in postoperative pain, sponsored by Pfizer. Started Sep 2002; status: terminated.

02

Drugs

parecoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00139607.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00139607.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call